10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-057832`
Period End Date	20170930
Filing Date	20171109
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	enzn-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 48 Cash Flow Statement 25

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$12.90M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$4.32M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$3.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$84.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$270.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.90M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.91M	USD	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$1.15M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$3.36M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$11.27M	USD	Point-in-time
Total assets	`Assets`	$9.05M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$213.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$770.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$170.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$158.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$371.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$940.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at September 30, 2017 and December 31, 2016	`CommonStockValue`	$441.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at September 30, 2017 and December 31, 2016	`CommonStockValue`	$441.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$90.28M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$83.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-80.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.33M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$8.68M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$11.27M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$9.05M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$8.37M	USD	3 Qtrs
Royalties	`RoyaltyRevenue`	$151.00K	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$7.46M	USD	3 Qtrs
Royalties	`RoyaltyRevenue`	$1.97M	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	-	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	-	USD	3 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$63.00K	USD	3 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$21.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$151.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$7.52M	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$1.99M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$8.37M	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.02M	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$376.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.53M	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$335.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.53M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.02M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$376.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$335.00K	USD	1 Quarter
Operating (loss) income and (loss) income before income tax (benefit) expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.61M	USD	1 Quarter
Operating (loss) income and (loss) income before income tax (benefit) expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.34M	USD	3 Qtrs
Operating (loss) income and (loss) income before income tax (benefit) expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-184.00K	USD	1 Quarter
Operating (loss) income and (loss) income before income tax (benefit) expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.99M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$2.36M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$674.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$2.50M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-337.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.98M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$3.49M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$153.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$936.00K	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.08	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.08	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.11	USD	3 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.21M	shares	3 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	3 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.22M	shares	1 Quarter
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.21M	shares	1 Quarter
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.21M	shares	1 Quarter
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	3 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.22M	shares	1 Quarter
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.21M	shares	3 Qtrs

Cash Flow Statement 25 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$4.98M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$3.49M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$153.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$936.00K	USD	1 Quarter
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$2.21M	USD	3 Qtrs
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$2.50M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$4.76M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$3.88M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.22M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.31M	USD	3 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	$6.63M	USD	3 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	-	USD	3 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	$6.60M	USD	Point-in-time
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.63M	USD	3 Qtrs
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.32M	USD	3 Qtrs
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.22M	USD	3 Qtrs
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.90M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.32M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.90M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.32M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.